ftInvstr
EXPLEOSOL · Technology ₹901.0 +0.33% Mkt Cap ₹1404 Cr fair

EXPLEOSOL

Technology Information Technology Services
₹901.0
+0.33% today · 30d +9.98%
as of 2026-09-04
Price · Daily Candles
“EXPLEOSOL's Q4 Profit Soars 73%: FIIs Increase Stake Amidst Technical Tailwinds”
EXPLEOSOL reported a significant Q4 2026 net profit increase of 73.08% YoY to ₹42 Cr, driven by an 11.92% YoY revenue growth to ₹286 Cr for the quarter. The company maintains an attractive dividend yield of 5.67% and trades with a PE of 11.35, notably lower than many sector peers, despite its 25.0% ROCE.
BULL CASE
+Quarterly net profit surged by 73.08% YoY to ₹42 Cr, with revenue up 11.92% YoY to ₹286 Cr for Q4 2026.
+The trailing twelve-month PE ratio is 11.35, offering a discount compared to sector giants like TCS (PE 16.97) and Infosys (PE 16.06).
+FIIs increased their holding by 0.1% QoQ, now owning 0.42% of the company as of March 31, 2026.
+The stock offers a dividend yield of 5.67%, significantly higher than the average offerings in the IT services sector.
+Both MACD and RSI(14) technical indicators show a moderate bullish state, signaling positive momentum.
BEAR CASE
Overall annual net profit CAGR for the last 3 years shows a decline of 2.53%, despite a 6.42% revenue CAGR over the same period.
The stock is trading 33.63% below its 52-week high of ₹1370.9, indicating recent price weakness.
ML predictions show a weak rank for FCF growth across all time horizons (e.g., FCF 1Y stable 7Y rank is 0.0).
Despite growth, the company's market capitalization of ₹1405 Cr is substantially smaller than peers like TCS (₹835127 Cr) and Infosys (₹472893 Cr).
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹292 Cr
+12.29% YoY
NET PROFIT
₹34 Cr
+67.34% YoY
OPM
16.51%
+2.75pp YoY
EPS
₹22.02
PE 11.35
Intrinsic value · DCF ₹1067.47 · Margin of safety +18.5% (fair) · FCF yield 8.3%
◇ Sector Position
EXPLEOSOL's PE of 11.35 positions it as a value play compared to its peers like TCS (PE 16.97) and Infosys (PE 16.06), while its 25.0% ROCE aligns with sector averages but is below leaders like TCS (ROCE 60.1%).
PEERPEROCE %
EXPLEOSOL11.3525.0
TCS16.9760.1
INFY16.0644.44
WIPRO16.4322.08
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
68
SCORE / 100
Overall
6-axis composite of the sections below.
Performance NEUTRAL 40
Valuation CHEAP 75
Growth STEADY 66
Profitability HIGH 85
Technicals STRONG 72
Risk LOW 70
Key Stats
TTM PE
11.35
P/B
1.82
52W HIGH
₹1175.1
OFF HIGH
-23.33%
DIV YIELD
5.67%
MKT CAP
₹1404 Cr
◉ Active Signals
MACDBullish0.8291
RSI(14)Neutral59.19
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold EXPLEOSOL and at what entry.

Sign up freeSign in